ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 568,90
-0,84%
Dow Jones
40 211,72
0,00%
DAX
18 483,70
-0,63%
Brent Oil
83,075
-1,50%
Bitcoin
63 805,30
-1,61%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) Actualités

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateHeureSourceTitreSymboleSociété
03/11/202113h30GlobeNewswire Inc.Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr. Urte GaykoNASDAQ:SMMTSummit Therapeutics Inc
12/10/202114h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
08/10/202114h30GlobeNewswire Inc.Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of DirectorsNASDAQ:SMMTSummit Therapeutics Inc
30/09/202115h00GlobeNewswire Inc.Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021NASDAQ:SMMTSummit Therapeutics Inc
30/09/202114h00PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021NASDAQ:SMMTSummit Therapeutics Inc
21/09/202122h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
12/08/202122h19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
11/08/202114h01GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021NASDAQ:SMMTSummit Therapeutics Inc
11/08/202114h00GlobeNewswire Inc.Summit Therapeutics Provides Update on Ri-CoDIFy TrialsNASDAQ:SMMTSummit Therapeutics Inc
05/08/202114h00PR Newswire (US)Acurx Pharmaceuticals Joins the Antimicrobials Working GroupNASDAQ:SMMTSummit Therapeutics Inc
12/07/202114h29GlobeNewswire Inc.Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Prese...NASDAQ:SMMTSummit Therapeutics Inc
01/07/202114h00GlobeNewswire Inc.Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePos...NASDAQ:SMMTSummit Therapeutics Inc
17/06/202117h01Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
08/06/202117h18PR Newswire (US)Crestone Joins Antimicrobials Working GroupNASDAQ:SMMTSummit Therapeutics Inc
08/06/202113h00GlobeNewswire Inc.Summit Therapeutics set to join Russell 3000® IndexNASDAQ:SMMTSummit Therapeutics Inc
03/06/202114h00GlobeNewswire Inc.Summit Therapeutics’ Upcoming Annual Shareholders’ MeetingNASDAQ:SMMTSummit Therapeutics Inc
18/05/202113h00GlobeNewswire Inc.Summit Therapeutics Announces Preclinical Candidate and Associated CARB-X Funding Support for the Treatment of Infections Cau...NASDAQ:SMMTSummit Therapeutics Inc
17/05/202114h00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2021NASDAQ:SMMTSummit Therapeutics Inc
14/05/202122h28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
12/05/202120h58GlobeNewswire Inc.Summit Therapeutics Announces Closing of $75 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
06/05/202114h00GlobeNewswire Inc.Summit Therapeutics Publishes Scientific Updates to Corporate WebsiteNASDAQ:SMMTSummit Therapeutics Inc
05/05/202118h47GlobeNewswire Inc.Summit Therapeutics’ Rights Offering Nearing Expiration Date; Robert W. Duggan Declares Intention to Fully Oversubscribe in...NASDAQ:SMMTSummit Therapeutics Inc
29/04/202122h36Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SMMTSummit Therapeutics Inc
21/04/202114h04GlobeNewswire Inc.Summit Therapeutics Announces Commencement of Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
31/03/202122h52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SMMTSummit Therapeutics Inc
26/03/202112h00GlobeNewswire Inc.Summit Therapeutics Announces Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
17/03/202112h00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 202...NASDAQ:SMMTSummit Therapeutics Inc
02/03/202123h35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SMMTSummit Therapeutics Inc
16/02/202113h33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SMMTSummit Therapeutics Inc
20/01/202122h37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Dernières Valeurs Consultées

NASDAQ
MDIV
First Trust VI Multi Ass...
NASDAQ
TLSA
Tiziana Life Sciences
NYSE
INXN
InterXion Holding NV
NASDAQ
CSCD
USOTC
NVZMF
Novonesis AS (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés